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Abstract
Background: One of the most effective current approaches to preventing stroke events is the reduction of lifestyle
risk factors, such as unhealthy diet, physical inactivity and smoking. In this study, we assessed the efficacy and usability
of the phone-based Computer-aided Prevention System (CAPSYS) in supporting the reduction of lifestyle-related risk factors.
Methods: A single-centre two-arm clinical trial was performed between January 2013 and February 2014, based on
individual follow-up periods of six months with 94 patients at high risk of stroke, randomly assigned to an intervention
group (IC: 48; advised to use the CAPSYS system) or a standard care group (SC: 46). Study parameters, such as blood
pressure, blood values (HDL, LDL, HbA1c, glycaemia and triglycerides), weight, height, physical activity as well as
nutrition and smoking habits were captured through questionnaires and medical records at baseline and
post-intervention and analysed to detect significant changes. The usability of the intervention was assessed based on
the standardised System Usability Scale (SUS) complemented by a more system-specific user satisfaction and
feedback questionnaire.
Results: The statistical evaluation of primary measures revealed significant decreases of systolic blood pressure (mean
of the differences = –9 mmHg; p = 0.03; 95% CI = [–17.29, –0.71]), LDL (pseudo-median of the differences = –7.9
mg/dl; p = 0.04; 95% CI = [–18.5, –0.5]) and triglyceride values (pseudo-median of the differences = –12.5 mg/dl;
p = 0.04; 95% CI = [–26, –0.5]) in the intervention group, while no such changes could be observed in the control
group. Furthermore, we detected a statistically significant increase in self-reported fruit and vegetable consumption
(pseudo-median of the differences = 5.4 servings/week; p = 0.04; 95% CI = [0.5, 10.5]) and a decrease in sweets
consumption (pseudo-median of the differences = –2 servings/week; p = 0.04; 95% CI = [–4, –0.00001]) in the
intervention group. The usability assessment showed that the CAPSYS system was, in general, highly accepted by the
users (average SUS score: 80.1).
Conclusions: The study provided encouraging results indicating that a computerised phone-based lifestyle
coaching system, such as CAPSYS, can support the usual treatment in reducing cerebro-cardiovascular risk factors and
that such an approach is well applicable in practice.
Trial registration: ClinicalTrials.gov Identifier: NCT02444715
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Background
Lifestyle risk factors, such as unhealthy diet, physical
inactivity and smoking, have a strong influence on the
personal risk of stroke. Reducing such risk factors is cur-
rently one of the most effective approaches to preventing
stroke events. According to the World Health Organiza-
tion (WHO), “most cardiovascular diseases can be pre-
vented by addressing risk factors such as tobacco use,
unhealthy diet and obesity, physical inactivity, high blood
pressure, diabetes and raised lipids” [1–3]. However, many
individuals have difficulties adhering to recommendations
concerning a healthy lifestyle, and long-term compliance
with such lifestyle changes is usually low. Early findings
in behavioural research support the assumption that the
mere task of self-monitoring increases habit awareness,
induces reflection on habits, and thus can provoke a posi-
tive change of the monitored behaviour [4]. Furthermore,
experience has shown that sustained contact is necessary
in order to support people in establishing andmaintaining
lifestyle changes [5].
In this context, the recently developed Computer-
aided Prevention System (CAPSYS) offers a cost-effective
automated solution combining remote surveillance of
individual cerebro-cardiovascular risk factors with tai-
lored advice [6]. Registered patients can access CAPSYS
through a phone interface, simply by dialling a land-
line number. In an automated dialog, patients are asked
to provide information about a predefined number of
risk factors (current nutrition, physical activity, smok-
ing, weight and blood pressure) by typing in the cor-
responding answers using the phone keypad. Based on
the patient’s answers, CAPSYS issues tailored feedback
aiming at motivating a positive change towards or main-
tenance of healthy, risk-reducing habits. The system has
been designed as a multi-language tool, in which the
languages German and French have already been imple-
mented and used within the trial. Clearly, a telephone as
a user interface requires sufficient hearing abilities by the
patients as well as the ability to understand and follow
the instructions and advice issued by the virtual lifestyle
coach. Consequently, this system is not appropriate for
use by persons with severe hearing impairments or cog-
nitive limitations. In cases of doubt, a patient’s cognitive
abilities can be evaluated by means of the Folstein mini-
mental state test [7]. On the other hand, there is no prob-
lem for patients with difficulties in articulation or speech
impediments to use CAPSYS, due to the fact that patient
interaction does not involve any speech input but is purely
limited to pressing buttons on the telephone keypad.
In order to assess the efficacy of the CAPSYS approach
concerning the reduction of stroke-related risk factors
as well as the usability of the system, a dedicated study
was designed and carried out, the results of which are
presented in this article.
Methods
In 2013 and 2014, a single-centre randomised controlled
trial was carried out at the Department of Neurology of
the Centre Hospitalier de Luxembourg. The study was
designed as a six-month, parallel-group two-arm trial
involving an intervention and a control group. Within this
six-month study with a relatively limited number of par-
ticipants, it was not possible to focus on the registration of
severe events, such as stroke or death. Instead, the study
concentrates on changes in different surrogate parame-
ters for stroke (systolic blood pressure, BMI, HDL, LDL,
HbA1c, glycaemia and triglycerides). A draft of the study
design has already been presented in [8].
Participants
Patients aged 20 and over were eligible for the study if
they had already suffered from a stroke or were at high
risk of stroke (at least two risk factors according to the
criteria described in [2, 9, 10]). The eligibility criteria are
summarised in Table 1. Patients’ stroke risk and thus their
suitability to participate in the CAPSYS study were eval-
uated by the treating neurologist based on the patients’
individual risk factor profiles.
Recruitment and randomisation
Potential study participants were approached in the
course of their regular consultations with their neurolo-
gist, where they were screened for eligibility. Prior to their
enrolment in the study, all participants signed a written
informed consent; 94 participants were randomised by
lot to one of two groups: Interventional Care (IC: 48, 34
[71%] male) or Standard Care (SC: 46, 29 [63%] male).
Participants were aged between 32 and 86 (SC: mean =
59.6; SD = 12.1; median = 59) (IC: mean = 60.7; SD =
11.3; median = 61). The major characteristics of the study
cohort are summarised in Table 2. Due to the specific
design of the intervention, the study had to be carried out
in an only partially blinded manner. It is inherent to the
CAPSYS approach that the treating neurologist performs
regular reviews of the data collected in the intervention
group. The need to have access to patient histories and
the possibility to contact patients at any time in case of
emerging situations has limited the use of blinding meth-
ods within the trial. However, in order to ensure the
validity of the study, the CAPSYS study team was sepa-
rated into three different groups: a) principal investigator
and treating neurologist responsible for the initial eligi-
bility check of potential study participants, b) hospital
research nurse responsible for patient recruitment and
randomisation, and c) healthcare researchers who per-
formed the statistical evaluation of the collected data by
using pseudonymised data sets. During the recruitment
meeting, patients were informed about the purpose of
the study and about the study approach. The CAPSYS
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Table 1 Eligibility criteria for the CAPSYS study
Inclusion criteria Exclusion criteria
Age: 20 and over;
At high risk of stroke:
Inability to fill out or to understand the
informed consent;
• Already suffered a stroke or Transient Ischemic Attack (TIA) or No signed informed consent;
• At least two risk factors for stroke:
– High blood pressure (systolic blood pressure ≥ 140mmHg) Dementia
– Overweight (BMI ≥ 25 kg/m2)
– Lowphysical activity (less than 30min. ofmoderate-intensity physical exercise perweek)
– Smoking
– Unhealthy diet
study design was approved by the Luxembourg National
Research Ethics Committee (CNER) (N° 201205/08) and
the National Commission for Data Protection (CNPD)
(T007990).
Intervention
In addition to the usual care, participants in the IC group
were advised to regularly call the phone-based prevention
system CAPSYS (preferably twice a week). In the course
of the recruitment process, they were carefully instructed
in the proper use of the system, and they were provided a
corresponding user manual in form of a leaflet.
The participants could access the CAPSYS system by
calling a specific land line number with their stationary
or mobile phones. After choosing their preferred lan-
guage (French or German) and authenticating themselves
with their individual patient number and PIN code, the
participants were posed the following questions:
• How many servings of fruits and vegetables have you
consumed yesterday?
• How many servings of whole-grain food have you
consumed yesterday?
• How many servings of sweets have you consumed
yesterday?
• Please enter your current weight.
Table 2 Descriptive statistics of the study cohort
SC (n = 46) IC (n = 48)
Mean age [years] (±SD) 59.6 (±12.1) 60.7 (±11.3)
Men 29 (63%) 34 (71%)
Mean BMI [kg/m2] (±SD) 27 (±4.3) 28 (±4.3)
Smokers 2 (4%) 6 (13%)
Hypertension 36 (78%) 43 (90%)
Hyper-/Dyslipidemia 39 (85%) 44 (92%)
Diabetes mellitus 5 (11%) 8 (17%)
Previous stroke/TIA 37 (80%) 31 (65%)
• How many cigarettes have you smoked yesterday?
[removed for non-smokers]
• How many minutes have you been physically active
yesterday? [moderate or high intensity]
• Please enter your current systolic blood pressure.
The participants could answer to these questions by typ-
ing in the numerical values (number of servings, weight,
minutes etc.) using the phone key pad. During the recruit-
ment meeting at the beginning of the study, participants
were instructed on how to estimate the size of one por-
tion for the relevant food groups, and they were advised
to measure their current blood pressure and weight, and
to write down all necessary values prior to calling the
CAPSYS system.
Depending on the data provided by the patient, he or
she received immediate customized feedback after each
answer concerning his or her progress and advice on
how to proceed reducing the corresponding risk fac-
tor or motivation on maintaining some observed healthy
behaviour respectively. The phone call was closed with
a concluding statement summing up the feedback issued
before by the system. The questions and feedback were
automatically generated by CAPSYS and were issued to
the patients in spoken natural language bymeans of a text-
to-speech software (TTS). The system was implemented
to run fully automatically and could be accessed at any
time of day.
In case of systolic blood pressure higher than 140
mmHg, the patient was advised to rest for a while and
then repeat the measurement. The system also advised
the patients to contact a doctor in case of constantly high
blood pressure. Patients with values above 140 mmHg
were also particularly marked in the web interface when
the treating physician accessed the system. Apart from
that, all participants have been informed that there were
no direct alerts in cases of high blood pressure provided
within the study.
The treating neurologist could access the data provided
by his patients through a web interface, offering both
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a numerical as well as an adaptable graphical represen-
tation of the patient data for a certain period of time.
The use of CAPSYS within the study has not replaced
or reduced the existing information exchange between
the neurologist and the corresponding referring physi-
cians, which was proceeded according to the practices
of the Luxembourgish healthcare system. Technically,
CAPSYS offers the possibility for further physicians, e.g.
the treating general practitioner, to access and moni-
tor the data gathered from their patients. However, in
the scope of this study, this option was deliberately dis-
carded in order to avoid potential bias caused by the gen-
eral practitioner accessing and interpreting the CAPSYS
data.
In contrast to the IC group, SC participants received
only the usual care including blood analyses, blood pres-
sure controls and individual advice on healthy lifestyle
during the outpatient treatment given by the neurolo-
gist, by the general practitioner and by other physicians.
Information material concerning a healthy lifestyle was
provided to both groups.
Data collection
Demographic and medical information of each partici-
pant was recorded by the study personnel in a predefined
form, including body weight and height, medical his-
tory, current medication, smoking habits, blood pressure
and heart rate as well as recent blood test results (HDL,
LDL, HbA1c, glycaemia and triglycerides). Furthermore,
participants were asked to fill in three questionnaires
exploring their nutritional habits, physical activity and
quality of life. The latter was measured using the stan-
dardised EQ-5D-5L instrument provided by the EuroQol
Group [11].
Six months after enrolment, participants were asked
to fill in the same questionnaires again, and current
medical data (weight, blood pressure, heart rate, blood
test results, smoking habits and medication) were again
recorded by the study personnel. In addition, IC partic-
ipants were asked to share their experiences with using
CAPSYS and to provide their opinions about the system in
a predefined questionnaire, which encompasses the well-
established System Usability Scale (SUS) [12] and some
further more specific questions concerning the usage of
CAPSYS and its particular features. There was also space
left for open-ended comments and suggestions at the end
of the questionnaire.
Dependent measures
The impact of the intervention was assessed based on the
changes of cerebro-cardiovascular risk parameters dur-
ing the six-month trial period, whereby changes in the
IC group were compared to those in the control group
(SC). Changes in systolic blood pressure, HDL, LDL,
HbA1c, glycaemia, triglycerides and BMI were considered
as primary dependent measures (see Table 3). Changes
in self-reported weekly consumption of fruits and veg-
etables, whole grain food and sweets as well as changes
in self-reported weekly duration of physical activity and
quality of life were analysed as secondary measures.
Due to the low number of smokers among the study
participants (SC: 2, IC: 6), smoking habits were not
evaluated.
Statistical analyses were carried out on an intention-
to-treat basis using RStudio (Version 0.98.978) with a
significance level of 0.05. Parametric data (paired and
unpaired samples) were evaluated with the Student’s t-test
approach, and the corresponding effect size was calcu-
lated with Cohen’s d. Non-parametric data were eval-
uated using the Wilcoxon signed-rank test (for paired
samples) or the Mann-Whitney U test (for unpaired
samples) respectively, and effect size was calculated as
r = Z√N . For non-parametric paired samples, the
pseudo-median is computed as the Hodges-Lehmann
estimate.
Results
Efficacy of the intervention
Final questionnaires on nutritional habits, physical activ-
ity and quality of life could be collected from 68 partici-
pants (SC: 36; IC: 32) at the end of the study. This results
in an overall dropout rate of 28% (SC: 22%; IC: 33%). Fur-
ther participant data, such as blood test values, could be
retrieved from medical records. Out of the 48 recruited
IC participants, 11 (23%) did not use CAPSYS at all. The
remaining 37 IC subjects (77%) called the system up to 55
times during the study period (mean = 23.32; SD = 14.1;
median = 24).
Within-subjects analyses of primary dependent mea-
sures showed the following statistically significant
changes between baseline and post-intervention:
• Decrease of systolic blood pressure in IC group
(two-sided paired-samples t-test: mean of the
differences = –9 mmHg; p = 0.03; 95% CI =
[–17.29, –0.71]; Cohen’s d = 0.42: large effect size)
(see Fig. 1), with no corresponding significant
difference in SC group (p = 0.96);
• Decrease of low-density lipoprotein (LDL) levels in
IC group (Wilcoxon signed-rank test: pseudo-median
of the differences = –7.9 mg/dl; p = 0.04; 95% CI =
[–18.5, –0.5]; r = 0.24: medium effect size), with no
corresponding significant difference in SC group
(p = 0.76) (see Fig. 2);
• Decrease of triglyceride levels in IC group (Wilcoxon
signed-rank test: pseudo-median of the differences =
–12.5 mg/dl; p = 0.04; 95% CI = [–26, –0.5]; r =
0.25: medium effect size), with no corresponding
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Table 3 Overview of baseline values and evaluation of primary dependent measures in SC and IC groups
SC IC
Baseline Evaluation Baseline Evaluation
Parametric data Mean (±SD) T-test Mean (±SD) T-test
Systolic BP [mmHg] 139.6 (±21) mean of diff. = 0.19 145 (±19.4) mean of diff. = −9
p = 0.96 p= 0.03*
95% CI = [–7.5, 7.88] 95% CI = [–17.29, –0.71]
Cohen’s d = 0.42
BMI [kg/m2] 27 (±4.3) mean of diff. = 0.03 28 (±4.3) mean of diff. = −0.18
p = 0.9 p = 0.43
95% CI = [–0.49, 0.55] 95% CI = [–0.65, 0.28]
Non-parametric data Median [IQR] Wilcoxon Median [IQR] Wilcoxon
HDL [mg/dl] 57 [45 , 51] pseudo-median of diff = 1.5 53 [47 , 74] pseudo-median of diff = −1.5
p = 0.53 p = 0.44
95% CI = [–2.5, 4.5] 95% CI = [–4.5, 2]
LDL [mg/dl] 96 [71 , 114] pseudo-median of diff = −1 95 [76 , 117] pseudo-median of diff = −7.9
p = 0.76 p= 0.04*
95% CI = [–10.5, 6] 95% CI = [–18.5, –0.5]
r = 0.24
HbA1c [ %] 5.8 [5.6 , 5.9] pseudo-median of diff = 0 5.9 [5.5 , 6.25] pseudo-median of diff = 0.1
p = 0.92 p = 0.37
95% CI = [–0.25, 0.2] 95% CI = [–0.1, 0.25]
Glycaemia [mg/dl] 98 [89 , 106.75] pseudo-median of diff = 0.5 102 [92.5 , 114.5] pseudo-median of diff = 2.5
p = 0.78 p = 0.19
95% CI = [–5.5, 5] 95% CI = [–2, 6]
Triglycerides [mg/dl] 95 [73 , 134.25] pseudo-median of diff = −6 105 [78 , 132.5] pseudo-median of diff = −12.5
p = 0.39 p= 0.04*
95% CI = [–21, 10] 95% CI = [–26, –0.5]
r = 0.25
(statistically significant values are marked in bold)
significant difference in SC group (p = 0.39) (see
Fig. 3);
• No statistically significant changes could be found for
any of the other primary measures (BMI, HDL,
HbA1c and glycaemia).
In this context, it needs to be stated that, at base-
line, there were no statistical differences between both
groups concerning the proportions of patients taking anti-
hypertensives (SC: 36 [78%]; IC: 43 [90%]; p = 0.22),
antidiabetic drugs (SC: 5 [11%]; IC: 8 [17%]; p = 0.61)
or cholesterol-lowering medication (SC: 39 [85%]; IC: 44
[92%]; p = 0.47).
Concerning the secondary dependent measures, we
could observe the following statistically significant results:
• Increase of self-reported fruit and vegetable
consumption in IC group (Wilcoxon signed-rank
test: pseudo-median of the differences = 5.4
servings/week; p = 0.04; 95% CI = [0.5, 10.5]; r =
0.26: medium effect size), with no corresponding
significant difference in SC group (p = 0.67);
• Decrease of self-reported sweets consumption in IC
group (Wilcoxon signed-rank test: pseudo-median of
the differences = –2 servings/week; p = 0.04; 95% CI
= [–4, –0.00001]; r = 0.26: medium effect size), with
no corresponding significant difference in SC group
(p = 0.06);
• Difference between SC and IC groups concerning the
change of self-reported whole-grain food
consumption (Mann-Whitney U test: difference in
location = 3.26 servings/week; p = 0.04; 95% CI =
[0.00006, 7]; r = 0.24: medium effect size);
• No statistically significant changes for self-reported
physical activity and quality of life.
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Fig. 1 Systolic blood pressure. Significant decrease of systolic blood
pressure in IC group
Usability and user acceptance of the intervention
Assessments of the intervention based on the System
Usability Scale (SUS) were provided by 28 participants
of the IC group, 2 of which were declared invalid, as
these participants have demonstrably never used CAP-
SYS during the trial period, and consequently, they were
considered unable to assess the intervention. The average
SUS score for CAPSYS was 80.1 (SD = 16.22; median =
78.75; min = 37.5; max = 100; 95% CI = [73.54, 86.65]).
According to Sauro and Lewis, this average score corre-
sponds to an “A–” school grade and a percentile of 85–89,
meaning that CAPSYS scored better than 85 to 89% of all
systems considered in the Sauro and Lewis study (see [13],
Fig. 2 LDL. Significant decrease of LDL levels in IC group
Fig. 3 Triglycerides. Significant decrease of triglyceride levels in IC
group
chapter 8, page 204, table 8.6). Using the simplified regres-
sion equation proposed by Lewis [14], the Likelihood to
Recommend for each CAPSYS user was derived from the
corresponding SUS scores as LTR = SUS/10. With these
values, we could identify 10 promoters (38%; LTR ≥ 9)
and 4 detractors (23%; LTR ≤ 6) among the 26 partici-
pants who provided valid SUS scores, which results in a
positive Net Promoter Score (NPS) of 23 [15], meaning
that there are 23% more users who would recommend
CAPSYS (promoters) than users who would argue against
using the system (detractors).
Beside the standardised SUS questionnaire, IC partic-
ipants were also asked to asses the voice of the text-
to-speech module applied in CAPSYS and the auto-
matically generated utterances issued by the system.
The results concerning these questions are presented in
Table 4.
Concerning the frequency of use, the majority of the
26 IC participants who answered to the usability ques-
tionnaire indicated that they would prefer using CAPSYS
once (11; 42%) or twice (9; 35%) per week. None of the
respondents was willing to use the systemmore than twice
a week, 2 (8%) preferred to use it less than once a week
and 4 (15%) expressed that they would not use it at all.
The approach of connecting to CAPSYS by calling the
system whenever they wish was favoured by most of the
respondents (18; 69%) over the potential alternatives of
being called by the system (3; 12%) or receiving reminders
to call the system (2; 8%). Although CAPSYS does not
offer speech recognition, we asked users if they prefer to
have such an input option instead or in combination with
the implemented keypad input. In this context, using the
phone keypad was identified as the most preferred way of
communication with such a system (20; 77%) as compared
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Table 4 Evaluation of CAPSYS’s voice and utterances
Scale Results
Voice 1: pleasant – 5: unpleasant mean = 1.77; median = 1.5; SD = 0.99
1: difficult to understand – 5: easy to understand mean = 4.28; median = 5; SD = 1.14
1: natural – 5: unnatural mean = 2.15; median = 2; SD = 1.12
1: too fast – 5: too slow mean = 3.2; median = 3; SD = 0.5
Utterances 1: diversified – 5: unvaried mean = 3.28; median = 4; SD = 1.24
1: inappropriate – 5: appropriate mean = 3.46; median = 3; SD = 1.07
1: too short – 5: too long mean = 3.2; median = 3; SD = 0.5
to speech input (1; 4%) or a combination of both (4; 15%).
The majority of the respondents were interested in hav-
ing insight into the data history gathered by CAPSYS,
either online (9; 35%) or in a printed version (11; 42%).
Concerning a potential alternative interface for CAPSYS
beside the phone interface, 10 (38%) participants were
interested in a corresponding website and 4 (15%) fancied
the idea of having a CAPSYS smartphone app. Regarding
the question if the use of CAPSYS has motivated them
to a healthier lifestyle, 5 (19%) of the respondents stated
that through the intervention they started eating healthier,
3 (12%) reported to have become physically more active
and 12 (46%) claimed to have achieved both healthier eat-
ing and increased physical activity. This means that, in
total, 20 (77%; 95% CI = [59%, 95%]) of the respondents
expressed an improvement of their health-related lifestyle
(improved nutrition or increased physical activity or both)
through the use of CAPSYS.
Discussion
The positive effects that could be observed in the IC group
concerning systolic blood pressure, LDL and triglyceride
levels as well as the self-reported improvements of nutri-
tional habits can be regarded as an indicator that a
computerised phone-based intervention, such as CAP-
SYS, can support the reduction of cerebro-cardiovascular
risk when offered in addition to usual care. An average
decrease in systolic blood pressure of 9 mmHg among CI
participants can be regarded as clinically significant [16].
The same also holds for the observed average decreases
of 7.9 mg/dl for LDL [17] and 12.5 mg/dl for triglycerides
[18]. Though, the relatively wide 95% confidence inter-
vals retrieved in the statistical analysis indicate that the
cohort size was probably too small to be able to demon-
strate strong clinical effects. The evaluation of BMI,
HDL, HbA1c and glycaemia values showed no significant
changes in the two groups.
Our results are to some extent supported by the recently
published Australian CLIP study, which found that tele-
phone coaching performed by human health care profes-
sionals can result in a significant reduction of LDL and
total cholesterol values in the intervention group [19].
A systematic review by Goode et al. also underlines the
efficacy of telephone-based lifestyle coaching. In 20 out
of 26 studies, telephone support by health professionals
have led to significant improvements concerning physi-
cal exercises and healthy nutrition [20]. However, personal
telephone coaching by health experts requires intensive
use of human resources and is associated with enormous
costs, which limits its widespread distribution to larger
patient groups.
CAPSYS is a system that supports prevention initiatives
by supporting individuals in daily life settings. It can be
assumed that a large percentage of the total target group
is not willing to perform any lifestyle changes at all, no
matter which kind of support they will receive. So, it has
to be taken into account that our study participants are a
selected subgroup of the target population with a poten-
tially highermotivation to change risk factors and lifestyle.
However, this selection bias in general concerns all pre-
vention initiatives, and the randomisation process should
ensure that the general motivation is balanced across both
study arms.
Compared to therapy studies, participants in preven-
tion studies mostly do not see any direct measurable
advantages in their actual health status. Missing short-
term improvements are therefore often a reason for higher
dropout rates. However, compared to other studies in sec-
ondary prevention, the moderate and balanced dropout
rates of both CAPSYS arms should not have signifi-
cantly affected the study results. On the other hand,
self-reported consumptions of fruits, vegetables or sweets
have a high potential for reporting bias. Therefore, in
our study, this kind of information is only considered as
secondary depended measures.
The improvements of nutritional habits in the IC group
(5 servings of fruits and vegetables more per week; 2 serv-
ings of sweets less per week) are significant, but have to
be treated with caution as they are based on self-reported
values and thus less reliable. As the dropout rates were not
significantly different for both groups (SC: 22%; IC: 33%;
p = 0.31), it can be supposed that the withdrawal of IC
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patients from the clinical trial was not substantially influ-
enced by the intervention itself, but it was due to common
reasons, like lack of time, forgetting appointments or just
lack of motivation. Furthermore, it remains open how the
observed positive effects will evolve after the study period
and if they actually are of a long-term nature.
The usability evaluation revealed that the CAPSYS
approach was well accepted by the study participants.
In particular, the large proportion of respondents (77%)
expressing a positive change of health-related behaviour
due to the use of CAPSYS is remarkable. One might argue
that this result is strongly biased due to the fact that
users who have a positive experience with a system are
more likely to finish a study and provide corresponding
feedback than users with negative experiences. However,
even if we consider all dropout IC participants as non-
beneficiaries, the success rate concerning a positive health
behaviour change would still be 42% (95% CI = [27%,
57%]). Unfortunately, our cohort was not large enough
to perform subgroup analyses in order to evaluate the
characteristics of beneficiaries and non-beneficiaries. A
follow-up study focussing on such aspects might help to
identify appropriate target groups for which a system like
CAPSYS might be most beneficial and most accepted.
During informal interviews at the end of the study, many
of the IC participants explained that they often could not
find the time or simply forgot to call CAPSYS. Taking
this into account, the implementation of a call reminder
functionality seems beneficial, even though in the feed-
back questionnaire, the majority of the respondents did
not favour the concepts of being called or reminded by the
system. Another important issue concerning risk factor
reduction in the stroke prevention context is the topic of
medication adherence. In order to support users in regu-
larly taking their antihypertensive or cholesterol-lowering
medication, CAPSYS could be extended to incorporate
prompts in its automatically generated feedback mes-
sages asking the users if they have taken their prescribed
medication according to their individual medication plan.
Concerning the technical implementation of CAPSYS,
it could be observed that, on average, the artificial voice
applied in CAPSYS was perceived as rather pleasant, easy
to understand and natural, and the speech rate was per-
ceived as appropriate. The length of the utterances was,
on average, perceived as adequate, but the feedback text
might also be shortened to some extent. The results also
show that there is some space for improvement con-
cerning the diversity and adequacy of the automatically
generated feedback.
The offered keypad interface for data input was highly
accepted by the users, and the need for an alterna-
tive input method, such as speech, was detected to be
low. Unsurprisingly, only few users were currently inter-
ested in a mobile app version of CAPSYS. However, with
increasing spread of smartphones, a mobile solution will
certainly gain in importance in the future. What is already
important for most users is to have access to their own
self-monitored data, even if due to technical reasons they
might only be able to access them in a printed form.
Conclusion
In summary, the present study provided encourag-
ing results indicating that a computerised phone-based
lifestyle coaching system, such as CAPSYS, can support
the usual treatment in reducing cerebro-cardiovascular
risk factors and that such an approach is in general well
accepted by the affected patients. In a next step, CAP-
SYS could be extended to a disease management tool,
involving health professionals from different disciplines,
such as neurologists, cardiologists, dieticians, physiother-
apists etc., in the treatment of patients. One aspect that
could be explored in future research is if the motiva-
tional effect of CAPSYS could be strengthened through
an increased involvement of the treating physician and
through incorporation of social interaction.
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